-
Product Insights
Innovation in construction: floating breakwaters
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the construction industry’s floating breakwaters segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Company Insights
NewVenmo – Competitor Profile
Founded in 2009, Venmo initially allowed users to send money via SMS. In late 2010, a Venmo app was launched. This was initially a payment service that focused on P2P payments and simple purchase transactions, such as payments to food trucks. Over the years, Venmo has expanded its use cases, allowing users to make payments to a wider range of merchants both online and offline via Venmo. Users can top up their accounts and link their app account to their...
-
Company Insights
NewApple Pay – Competitor Profile
Apple Pay is a mobile payment solution launched by Apple in October 2014. It allows users to store their payment card details to use for future payments. Users hover their mobile device near a contactless terminal and authenticate the transaction via Touch ID, Face ID, or PIN depending on the Apple device used. The solution is accepted at millions of retail outlets globally and supports all major payment networks. Apple Pay is supported by more than 6,600 banks and financial...
-
Thematic Analysis
NewState of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update) – Thematic Intelligence
Reasons to buy the ‘State of the Biopharmaceutical Industry 2024’ thematic intelligence report: Highlight the business environment and the industry, regulatory, and macroeconomic trends that are going to shape the biopharmaceutical industry in the next 12 months. Benchmark the impact of major themes on the biopharmaceutical industry in the next 12 months, Identify themes that will have the greatest positive or negative impact in the coming months. Comprehend the opinions of industry respondents on these themes. Predict the industry’s growth prospects...
-
Thematic Analysis
NewHigh-Performance Computing – Thematic Intelligence
High-Performance Computing Thematic Intelligence Report Overview High-performance computing (HPC) is the use of supercomputers and parallel processing techniques to solve complex computational problems. HPC started as an array of independent monolithic systems and evolved into clusters that can run on hundreds of thousands of processors. The Internet of Things has created a data explosion. As the volume of IoT data increases, so does the amount of data that needs to be processed and stored, driving organizations globally to use high-performance...
-
Product Insights
NewComputed Tomography (CT) Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Computed Tomography (CT) Systems Pipeline Market Report Overview Computed Tomography (CT) is a powerful and non-destructive evaluation technique used for producing 2D and 3D cross-sectional images of an object from a flat X-ray image. It is used on patients with a high risk of colon cancer or full-motion heart scans for patients with a high risk of heart disease. The CT systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at...
-
Company Insights
NewAlipay – Competitor Profile
Launched in 2004, Alipay is among the leading alternative payment services providers (PSP) globally. It is a subsidiary of Ant Group, which is controlled by Alibaba Group. Alipay allows users to make fund transfers as well as online, in-app, and in-store payments at home and abroad. It is the primary method of payment for Alibaba’s online marketplaces, including AliExpress, Tmall, and Taobao. Alipay is accepted in more than 110 countries, allowing Chinese tourists to make payments in Chinese renminbi and...
-
Thematic Analysis
NewCybersecurity in Sport – Thematic Intelligence
Cybersecurity in Sport Thematic Intelligence Report Overview The business of sport naturally accrues a large amount of sensitive data. Sports teams, federations, broadcasters, and sponsors are all vulnerable to attacks due to their significant revenues, the exposure any attack will receive, and the multiple entry points that result from their distributed communications. Events and international bodies provide a global stage for hackers. Nation-state-sponsored attacks have occurred in the sports industry, usually in response to regulations and sanctions against countries and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ustekinumab Biosimilar in Plaque Psoriasis (Psoriasis Vulgaris) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sym-023 in Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sym-023 in Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sym-023 in Lymphoma Drug Details: Sym-023 is under development for the treatment...